ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 152 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $97,000 | -71.9% | 75,754 | -24.2% | 0.00% | -75.0% |
Q2 2019 | $345,000 | -31.0% | 99,906 | +1.3% | 0.00% | -33.3% |
Q1 2019 | $500,000 | +40.8% | 98,635 | +0.2% | 0.01% | +20.0% |
Q4 2018 | $355,000 | -34.9% | 98,465 | +6.2% | 0.01% | 0.0% |
Q3 2018 | $545,000 | – | 92,719 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 64,315 | $326,000 | 0.69% |
PERKINS CAPITAL MANAGEMENT INC | 130,600 | $662,000 | 0.44% |
Senvest Management, LLC | 1,000,140 | $5,071,000 | 0.38% |
Matarin Capital Management, LLC | 827,462 | $4,195,000 | 0.30% |
DELTEC ASSET MANAGEMENT LLC | 271,543 | $1,377,000 | 0.30% |
GLOBEFLEX CAPITAL L P | 214,103 | $1,086,000 | 0.23% |
TSP Capital Management Group, LLC | 58,050 | $294,000 | 0.15% |
Spark Investment Management LLC | 538,443 | $2,729,000 | 0.13% |
Connor, Clark & Lunn Investment Management Ltd. | 3,134,905 | $15,894,000 | 0.10% |
FIRST QUADRANT LLC/CA | 245,756 | $1,246,000 | 0.10% |